IL6 and congenital rubella syndrome: Two major toxicities experienced by CAR T-cell recipients are CRS, a syndrome characterized by severe systemic inflammation with elevations in IL-6 and IFN-γ that occurs in the vast majority of patients treated, and neurotoxicity, which can range in severity from seizures to death40.